Patient Success Stories: Real Resultsfrom Non-Surgical Pain Treatment
These are clinic patients, not actors. 10,000+ people treated since 2011. In a 2019–2024 knee cohort, 89% avoided replacement. Watch the videos. Then decide if the bloodwork visit is worth it.
"Within 15 days, I felt five years younger. His therapy is nothing short of a blessing for those living with chronic pain."
Sri Sunil Shastri
"Press conference footage: patients describing what changed after the non-surgical protocol."
Press Conference Patient
"I was diagnosed with severe osteoarthritis. OPTM's non-surgical treatment helped me recover and get back to my normal life."
Susama Paul
"The joint pain and osteoarthritis were making daily tasks impossible. OPTM changed everything for me and restored my mobility."
Ms. Reenu
"Living with muscle pain and dystrophy was a constant struggle. Finding OPTM gave me a new lease on life."
Ms. Ruchi
What these visits actually involved
Most of the people above had already been told to book a replacement. They did the same three things: a 60+ biomarker assessment, plant-molecular therapy for the biology we found, and Movement RX so the pain did not walk back in. That took weeks, not a weekend.
Patients treated since 2011
Avoided knee replacement surgery (2019–2024 cohort)
Reported treatment success (OPTM internal audit)
Outcome figures are drawn from OPTM internal cohort and audit data. Individual results vary — see our research and Bio-Musculo Index pages for methodology.
Conditions featured in these stories
Scientific Evidence Base
The biomarkers measured in OPTM's diagnostic panel are grounded in peer-reviewed medical literature.
About the Bio-Musculo Index Methodology
The Bio-Musculo Index (BMI) is a proprietary multi-biomarker diagnostic panel developed by Dr. Apurba Ganguly (PhD Biochemistry, DSc, Post-Doctorate Fellow) over 35+ years of clinical research. It aggregates individually validated blood biomarkers — including inflammatory cytokines, oxidative stress markers, cartilage degradation indicators, and metabolic parameters — into a composite AI-assisted index. Dr. Ganguly's own peer-reviewed publications (indexed on NIH/PubMed, ResearchGate, IABCR, and Longdom Publishing) form the primary evidence base for this protocol.
All citations below are authored or co-authored by Dr. Apurba Ganguly — Founder & Chief Research Officer, OPTM Healthcare. View full publication list at ResearchGate or SciProfiles.
Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels
Ganguly A, Ganguly Anondeep. (2025). Molecular signatures of varicosity: Diagnostic insights from ten biomarker panels. PubMed Central (NIH). PMC12694810.
View Publication →Relevance: Dr. Ganguly's 2025 NIH-indexed research on multi-biomarker diagnostic panels — the methodology used in OPTM's Bio-Musculo Index
Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention
Ganguly A. Pain diagnostic protocol and topical phytotherapeutic treatment for osteoarthritic disorders and prevention. International Online Medical Council (IOMC) Proceedings.
View Publication →Relevance: Dr. Ganguly's clinical research on OPTM's pain diagnostic and phytotherapeutic treatment protocol for osteoarthritis
Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis
Ganguly A. (2024). Efficacy of Phytotherapeutic Protocol for the Risk Factor Reduction in Musculoskeletal Degeneration: A Systematic Meta-Analysis. International Archives of BioMedical and Clinical Research (IABCR), Vol. 10, Issue 1, Mar 2024.
View Publication →Relevance: Dr. Ganguly's peer-reviewed meta-analysis validating OPTM's phytotherapy protocol for musculoskeletal risk factor reduction
If this sounds like your week, book the assessment
The first visit is bloodwork and a written plan. Not a surgery date. Assessment includes the 60+ biomarker panel.